Patents by Inventor Raffael SCHUECKER

Raffael SCHUECKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240116881
    Abstract: Processes for preparation of ipconazole, processes for preparation of a compound of formula (V) and processes for preparation of a compound of formula (VI), which is a key intermediate useful for preparation of ipconazole are disclosed.
    Type: Application
    Filed: September 13, 2023
    Publication date: April 11, 2024
    Inventors: Sebastian Ebner, Johann Hiebl, Michael König, Samuel Ruehs, Raffael Schuecker, Cameron Gibb
  • Patent number: 10064961
    Abstract: A method for producing a liquid pharmaceutical preparation which contains a complex consisting of DOTA and gadolinium and a base such as L-lysine or meglumine, includes the following steps: a) An aqueous solution containing free DOTA, free gadolinium and a base such as L-lysine or meglumine is produced. b) The yield of free DOTA and free gadolinium is determined in the solution obtained according to step a). c) Free gadolinium and/or free DOTA is added in order to adjust a stoichiometric excess of free DOTA in the solution. d) The complexation is executed at an increased temperature. e) Additional base such as L-lysine or meglumine is added in order to adjust the pH value. f) The final volume of the preparation is adjusted.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: September 4, 2018
    Assignee: SANOCHEMIA PHARMAZEUTIKA AG
    Inventors: Stefan Welzig, Raffael Schuecker, Beate Kaelz, Jozsef Gungl, Klaus Gerdes, Roswitha Braunrath
  • Publication number: 20170216462
    Abstract: A method for producing a liquid pharmaceutical preparation which contains a complex consisting of DOTA and gadolinium and a base such as L-lysine or meglumine, includes the following steps: a) An aqueous solution containing free DOTA, free gadolinium and a base such as L-lysine or meglumine is produced. b) The yield of free DOTA and free gadolinium is determined in the solution obtained according to step a). c) Free gadolinium and/or free DOTA is added in order to adjust a stoichiometric excess of free DOTA in the solution. d) The complexation is executed at an increased temperature. e) Additional base such as L-lysine or meglumine is added in order to adjust the pH value. f) The final volume of the preparation is adjusted.
    Type: Application
    Filed: June 15, 2015
    Publication date: August 3, 2017
    Inventors: Stefan WELZIG, Raffael SCHUECKER, Beate KAELZ, Jozsef GUNGL, Klaus GERDES, Roswitha BRAUNRATH